Thursday, June 18, 2015

Ventana Receives FDA Approval for Lung Cancer Diagnostic

… ALK-targeted therapy within days."   Lung cancer is the leading cause of … patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)